Mankind Pharma Acquires Rivotril Brand From Roche India in Strategic Portfolio Expansion
Indian pharmaceutical company Mankind Pharma has acquired the rights to the well-known neurological medication brand Rivotril from Roche India, marking a significant strategic move in the country’s pharmaceutical landscape. The transaction is expected to strengthen Mankind Pharma’s presence in the central nervous system (CNS) therapy segment, one of the fastest-growing areas in healthcare.